IBM Just Placed a Billion-Bet to Become NVIDIA in Quantum
IBM bets big on quantum computing with a multi-year, $10+ billion plan aimed at transforming it into a leading hardwa...
Which Cards Have The Best Benefits
Discover which cards have the best benefits to maximize your rewards. Make informed choices for better financial outcomes.
26,924 articles
Oil Holds Near $94 as Markets React to June 2026 Supply
Oil prices hovered around $94 a barrel on June 10, 2026, after a modest daily dip. This article explains what the cur...
South Korea Fines Coupang Record $409 Million Data Breach
A regulatory ruling in Seoul levies a record penalty on Coupang for a data breach affecting tens of millions of accou...
AMD Stock Signals 129% Year-To-Date Flashing Light
AMD’s stock has surged this year on AI demand, trading near $480 after a 129% year-to-date rally. A 129% year-to-date...
Nvidia Amd: Better Stock for AI Wins in June Market
Nvidia dominates AI data centers as AMD gains with Meta-backed AI deployments. The June debate centers on whether nvi...
Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
SpaceX Rally Extends Elon: Crypto Traders Eye New Highs
SpaceX stock rose again Monday after Elon Musk signaled a possible $1 trillion in annual revenue by 2030, fueling a b...
BlackRock Rolls Bitcoin Income ETF to Expand Crypto Yield
BlackRock unveils the iShares Bitcoin Premium Income ETF, BITA, a yield-focused crypto product using an active covere...
Mercadolibre Stock After Insider: Is It Worth a Buy?
A senior MercadoLibre executive recently disclosed an open-market purchase, prompting questions about what this means...
How Consumers Using AI Are Shaping the Real Estate Role
AI adoption among homebuyers is accelerating, but many still want human guidance at key moments. This report examines...
Home Flipping Slowed Early, but Returns Tick Up in 2026
Flipping activity cooled in Q1 2026 while profits edged higher, signaling a cautious rebound after a downturn. ATTOM ...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status